Jenna Meyer
- Lymphoma
Nobody expects to get cancer in their 20s, but I was 28 when I was diagnosed with Hodgkin lymphoma.
Shazia K. Nakhoda, MD
Assistant Professor, Department of Hematology/Oncology
Hematology-Lymphoma Program
Specialties
- Hematology Oncology
Areas of Expertise
Myeloma, Lymphoma, Leukemia
Treatment Focus
Malignant Hematology; Central Nervous System Lymphoma
Distinctions
Treatment Philosophy
Navigating a new cancer diagnosis can be challenging and overwhelming. I feel honored to be part of a team that provides patients and their families not only specialized oncologic care, but also the support and resources needed. The collaborative network of clinicians, nurses, and researchers at Fox Chase allows me to provide my patients individualized treatment options, novel therapies, and access to clinical trials. In addition, I strive to provide my patients and their families compassionate and comprehensive clinical care throughout each aspect of their journey.
Clinical Locations
-
Fox Chase Cancer Center333 Cottman Avenue
Philadelphia, PA 19111
Phone: 888-369-2427
Educational Background
- Hematology & Oncology Fellowship Training, Temple University and Fox Chase Cancer Center, Philadelphia, PA, 07/2017-06/2020
- Internal Medicine Residency Training, University of Maryland Medical Center, Baltimore, MD, 6/2014-06/2017
- MD, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, 2014
Certifications
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Hematology
- American Board of Internal Medicine - Medical Oncology
Memberships
- American Society of Clinical Oncology
- American Society of Hematology
Honors & Awards
- Philadelphia Magazine Top Doctors, 2024-2026
- Awarded Honorable Mention for the Arnold R. Weitz, M.D. Memorial Prize in Hematology, 2014
Selected Publications
Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment Strategies. Nakhoda SK, Olszanski AJ. Pharmaceut Med. 2020 Apr;34(2):83-91. doi: 10.1007/s40290-020-00326-z. PMID: 32157638
Use of the APACHE II score to assess impact of therapeutic plasma exchange for critically ill patients with hypertriglyceride-induced pancreatitis. Nakhoda S, Zimrin AB, Baer MR, Law JY. Transfus Apher Sci. 2017 Apr;56(2):123-126. doi: 10.1016/j.transci.2016.10.005. Epub 2016 Oct 17. PMID: 27789124 Clinical Trial.
Additional Publications
Patient comments
Dr. Nakhoda is phenomenal. She takes the time to listen carefully to my concerns, thoroughly researches issues when needed, and has a wide network of contacts to help with other health-related needs. I never feel rushed during appointments, and she always makes me feel heard and valued as a patient. I couldn't ask for a better doctor and highly recommend her.
Doctor was kind, compassionate, smart, trustworthy, enthusiastic and helpful. The best!
Dr. Nakhoda is is one of the finest physicians I have been treated by (over my 77 years) and I have have some exceptional doctors. I am thrilled to have her leading my team..
Dr. Nakhoda is a true professional and an asset to her patients. I cannot say enough good things about her demeanor, compassion, and, most importantly, her expertise. I'm very fortunate to have been seen by such an amazing doctor.
There is not much more I can say about the staff and Dr. Nakhoda. This was as pleasant an experience as can be expected under the circumstances.